Efficacy of ultra-short, response-guided sofosbuvir and daclatasvir therapy for hepatitis C in a single-arm mechanistic pilot study. (2023)

First Author: Flower B

Attributed to: Blood borne viruses funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.7554/elife.81801

PubMed Identifier: 36622106

Publication URI: http://europepmc.org/abstract/MED/36622106

Type: Journal Article/Review

Volume: 12

Parent Publication: eLife

ISSN: 2050-084X